| All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer H Tawfik, Y Rostom, H Elghazaly Cancer chemotherapy and pharmacology 71 (4), 913-919, 2013 | 21 | 2013 |
| All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer–a phase II study H Shawky, H Tawfik Journal of the Egyptian National Cancer Institute 26 (4), 187-194, 2014 | 15 | 2014 |
| Primary Gastrointestinal Non-Hodgkin's Lymphoma: A Retrospective Study with Emphasis on Prognostic Factors and Treatment Outcome HSH Tawfik Journal of the Egyptian National Cancer Institute 20(4):330-41, 2008 | 15 | 2008 |
| Primary gastrointestinal non-Hodgkin’s lymphoma: a retrospective study with emphasis on prognostic factors and treatment outcome H Shawky, H Tawfik J Egypt Natl Canc Inst 20 (4), 330-41, 2008 | 15 | 2008 |
| Weekly dose-dense paclitaxel and carboplatin in recurrent ovarian carcinoma: a phase II trial H Shawky, H Tawfik, M Hewidy Journal of the Egyptian National Cancer Institute 26 (3), 139-145, 2014 | 9 | 2014 |
| Induction Docetaxel and Cisplatin Followed by Weekly Docetaxel and Cisplatin with Concurrent Radiotherapy in Locally Advanced Stage III Non Small Cell Lung Cancer (LA-NSCLC)-A … HA Tawfik, T Ael-H, GA Attia Journal of the Egyptian National Cancer Institute 19 (1), 15-20, 2007 | 7 | 2007 |
| Vinorelbine and capecitabine combination as first-line treatment in patients with metastatic breast cancer: final results of a multicentric trial in Egypt H Elghazaly, H Tawfik, M Mahrous, MM Meshref, A Sakr, N Haddad Journal of Clinical Oncology 26 (15_suppl), 1125-1125, 2008 | 3 | 2008 |
| Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts H Elghazaly, N Mottet, J Garcia, S Oudard, M Roach, C Abbou, ... World Journal of Urology, 1-9, 2020 | 1 | 2020 |
| Polymorphism of 8-oxoguanine DNA N-glycosylase 1 gene in Egyptian patients with larynx cancer AH Abd Elhameed, HA Tawfik, WS Ibrahim, SM El-Kabbany Madridge J Oncogen 1 (1), 8-11, 2017 | 1 | 2017 |
| Genetic Variations of Selected Genes Using Target Deep Sequencing in Colorectal Cancer Patients SMAHT Eman Farghal, Marwa H Saied, Fatma M Ghaith, Journal of Cancer Science and Therapy 9(10)(10):683-689, 2017 | 1* | 2017 |
| Genetic Variations of Selected Genes Using Target Deep Sequencing in Colorectal Cancer Patients Journal of Cancer Science & Therapy 9 (10), 683-689, 0 | 1* | |
| Can hENT1 Predict Survival in Locally Advanced Pancreatic Carcinoma Received Gemcitabine Monotherapy? EAHSWMS Hesham Tawfik1*, Sarah M. F. Ahmed1 Madridge Journal of Oncogenesis 1000108 (Issue 1), 47-51, 2018 | | 2018 |
| Predictive and Prognostic Value of Human Equilibrative Nucleoside Transporter 1 in Advanced Pancreatic Carcinoma H TAWFIK, MFA SARAH, WM SAID, AH EIMAN The Medical Journal of Cairo University 86 (September), 2823-2831, 2018 | | 2018 |
| Weekly dose-dense paclitaxel and carboplatin in recurrent ovarian carcinoma: A phase II trial - dense paclitaxel and carboplatin in recurrent ovarian carcinoma: A phase II … HTMH Hanan Shawky 03/2017, , At: LONDON, UK, Conference: THE INTERNATION AL CONGRESS ON CLINI …, 2017 | | 2017 |
| Sequential versus concomitant chemoradiotherapy in locally advanced head and neck cancer H Tawfik, A El-Aziz Research in Oncology 10 (1-2), 26-33, 2014 | | 2014 |
| The Impact of Tumor Phenotype (Hormone receptor and HER-2) Discordance during Breast Cancer Progression on Patient Management and Survival AEAM Hesham Tawfik, Hesham Elhamzawy, Life Science Journal, 2014 | | 2014 |
| Maintenance Versus Observation After Maximum Response with TFOX (Docitaxel, Florouracil, Oxaliplatin) Regimen in Metastatic Gastric Cancer (MGC) H Elghazaly, H Tawfik, K Nasr Annals of Oncology 24, iv61, 2013 | | 2013 |
| FOLFIRINOX as first–line therapy in metastatic pancreatic carcinoma (MPC) H Tawfik, H SHAWKY Annals of Oncology 24, iv83, 2013 | | 2013 |
| Brain Metastases in Triple Receptor-Negative Breast Cancer: Frequency, Risk Groups and Prognosis. H Tawfik | | 2013 |
| FOLFIRINOX as first–line therapy in metastatic pancreatic carcinoma (MPC) H TAWFIK, H SHAWKY Annals of Oncology, 2013 | | 2013 |
